We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Upper Tribunal Administrative Appeals Chamber decision of Judge Perez on 28 February 2020.
Aspire Pharma Limited is recalling the below batches of Bimatoprost Aspire 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 as a precautionary measure.
Product defect recall alert for: Otodex Skin Cream (Vm 13240/4000) by Petlife International Ltd
Ovarian Cancer Action, Beat, and Women in Prison among those receiving grants over £1m.
A user experience evaluation conducted by the Home Test Service in collaboration with the Royal National Institute of Blind People, the Macular Society, the Thomas Pocklington Trust, Visionary and the Torch Trust.
FDC Pharma are recalling batch 087B087 due to an out of specification result for an unknown impurity during stability testing. (EL(18)A/08)
(Allergan Limited) Small number of complaints have been received about small black particles found on or around the nozzle of the tube (EL (15)A/08).
The European Medicines Agency (EMA) has reiterated safety messages on Buccolam oral syringes for parents and caregivers.
Period product company scooped the title for its novel menstruation product, the Tampliner.
The European Commission has published an amendment to the Cosmetic Products Regulations
This letter from Professor Sally Davies, Chief Medical Officer, explains about recommendation from the Medicines and Healthcare Products Regulatory Agency on PIP breast implants.
Letter from the Chief Medical Officer regarding PIP breast implants. Download PIP Silicone Gel Breast Implants (PDF, 65K)
Letters were sent about Pharmalgen (Bee Venom and Wasp Venom) Initial kits, bendamustine (Levact), and ERWINASE.
In December 2015, a letter was sent to healthcare professionals regarding Reminyl (galantamine hydrobromide).
Upper Tribunal Administrative Appeals Chamber decision by Judge Mitchell on 3 November 2018
Employment Tribunal decision.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).